Securities Code: 000739
Securities Abbreviation: Pro-Health Pharma
Announcement No.: 2026-71
Pro-Health Pharmaceutical Co., Ltd.
Announcement on Obtaining Drug Registration Certificate
The Company and all members of the Board of Directors guarantee the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Recently, Zhejiang Pro-Health Pharmaceutical Co., Ltd. (hereinafter referred to as "Pro-Health Pharma"), a holding subsidiary of Pro-Health Pharmaceutical Co., Ltd. (hereinafter referred to as "Kangyu Pharma"), received a "Drug Registration Certificate" for Cinnarizine Sustained-Release Tablets issued by the National Medical Products Administration (hereinafter referred to as "NMPA"). The relevant situation is hereby announced as follows:
I. Drug Registration Approval Status